WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 48'1601 Infant (under 12 months) mortality rate: 42
GDP / capita (US$): 43'3241 Child (under 5 years) mortality rate: 42

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 8'464  8'433  8'402  8'372  8'342  8'020  7'670  7'555 
Births 80  79  79  78  78  80  90  89 
Surviving infants 80  79  78  78  77  80  89  87 
Pop. less than 5 years 402  397  395  394  397  419  442  423 
Pop. less than 15 years 1'230  1'233  1'239  1'253  1'271  1'367  1'337  1'538 
Female 15-49 years 2'018  2'032  2'043  2'050  2'052  1'991  1'962  1'819 

Number of reported case

(Click for retrospective incidence data for Austria)
Diphtheria
Japanese encephalitis
Measles 36  68  52  49  448 
Mumps
Pertussis 571  309  414  183  183  117  234  186 
Polio*
Rubella 23  252 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Austria)
Vaccine year result method % card seen                                                
BCG         
DTP1          61  65  75 
DTP3          83  83  81  90 
HepB_BD          65 
HepB3          83  83  33 
Hib3          83  83  72 
JapEnc         
MCV          76  83  75  60 
MCV2          64  62  35 
PCV1         
PCV3         
Pol3          83  83  71  90 
Rota1          67 
Rota_last          61  47 
Rubella1          76  83 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Austria)
BCG 90 
DTP1 93  93  93  93  97  99  96  96 
DTP3 83  83  83  83  83  81  90  90 
HepB3 83  83  83  83  83  33 
Hib3 83  83  83  83  83  72 
MCV 76  76  76  76  83  75  60 
PCV3
Pol3 83  83  83  83  83  71  90  90 
Rota_last 61  61  61  61  47 

Number of districts in the country 121  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaPHibHepIPV 0-1 year (x3); 1-2 years; Yes
HPV 9 years; (x3) Yes private sector
HepB 12-13 years; Yes school-booster
MMR 1-2 years (x2); Yes second dose earliest 28 days after first dose; catch-up vaccination at any age
Pneumo_conj 0-1 year (x3); 1-2 years; Yes children belonging to defined high risk groups
Rotavirus 7 weeks - 6 months (x2 or 3); Yes 3rd dose depending on vaccine

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR       Yes  Yes  Yes  Yes 
What years does the MYP cover? number       1998 - ongoing  1998 - ongoing  1998 - ongoing  1998 - ongoing 
Nº of districts with microplans that include activities to raise immunization coverage number              

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR              

System performance

Total number of districts in country number 121  121  121  121  121  121  121 
Nº districts with DTP3 coverage >=80% number              
% of districts with DTP3 coverage >=80% From 0 to 100%              
Nº districts with measles (MCV1) coverage >=95% number              
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR       Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND              

Finance

Percentage of routine vaccines funded by Government From 0 to 100%       83  83  88  88 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.